Read more

CORPORATE GOVERNANCE

LBC's Corporate Governance highly rated by One of the Big Four Accounting Firms

For details of the corporate governance review, click here.

Lereno Bio-Chem Ltd (the "Company") is committed to ensuring and maintaining a high standard of corporate governance within the Group to ensure transparency and protection of the interests of the Company's shareholders.

To facilitate effective management, the Board has formed Board Committees to assist in carrying out and discharging its duties and responsibilities efficiently and effectively.

Namely:

the Audit Committee (AC);

Name Designation
Peter John Farrar Chairman of AC and
Non-Executive & Independent Director
Wong Heang Fine Member and Non-Executive & Independent Director
Yap Boh Pin Member and Non-Executive & Independent Director

the Remuneration Committee (RC);

Name Designation
Tan Sri Dato'
Kamaruzzaman Bin Shariff
Chairman of RC and
Non-Executive & Independent Director
Wong Heang Fine Member and
Non-Executive & Independent Director

the Nominating Committee (NC);

Name Designation
Yap Boh Pin Chairman of NC and
Non-Executive & Independent Director
Tan Sri Dato'
Kamaruzzaman Bin Shariff
Member and Non-Executive & Independent Director
Peter John Farrar Member and Non-Executive & Independent Director

A Risk Management Committee (RMC) has also been formed in May 2007:

Name Designation
Wong Heang Fine Chairman of RMC and
Non-Executive & Independent Director
Ong Puay Koon Member, Managing Director & Chief Executive Officer
Ong Choon Lui Member and Executive Director
Lim Leong Kiat Member, Deputy President & Chief Financial Officer

The Risk Management Committee reviews the overall risk management guidelines / framework, reviews and recommends risk limits, assesses the adequacy and effectiveness of the risk management policies and systems to assist in reviewing the risks for transactions above S$5,000,000.

Our corporate governance report found in the Company's Annual Report 2009, describes the main corporate governance framework and practices of the Company with specific reference made to each of the principles of the Code of Corporate Governance 2005 (the "Code"), which forms part of the Continuing Obligations of the Singapore Exchange Securities Trading Limited ("SGX-ST")'s Listing Manual. The Company will continue to enhance its systems and corporate governance processes to ensure compliance with the Code.

For details of the report, click here

 

 

 

 
All Rights Reserved. Copyright © 2007 Lereno Bio-Chem Ltd. Company Reg. No. 197401961C
General Disclaimer
Designed by Infinite Sparks